Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

Synlait’s best move? Not getting rid of Dairyworks
Opinion Stock & Trade

Stock & Trade: Synlait’s best move? Not getting rid of Dairyworks

Consumer dairy goods business almost went in a Synlait fire sale.

Stock & Trade 28 Nov 2025
Pāmu upgrades profit guidance
Primary Sector

Pāmu upgrades profit guidance

That's despite this week's milk price cut.

Riley Kennedy 27 Nov 2025
Critical minerals miner plans 2026 NZX listing
Primary Sector

Critical minerals miner plans 2026 NZX listing

The company plans to raise $20m from retail investors in mid-2026.

Pattrick Smellie 26 Nov 2025
Ruminant Biotech closes $17 million series A raise
Primary Sector

Ruminant Biotech closes $17 million series A raise

The agritech start-up plans its commercial launch in NZ and Australia next year.

Greg Hurrell 26 Nov 2025